2025 ACA Winter Conference Orlando_Program Book

Across the U.S., opioid use and overdose deaths are at epidemic proportions. In 2017, 2.1 million people in the United States had an opioid use disorder (OUD) and nearly 68 percent of overdose deaths involved opioids. Opioid overdose deaths have reduced the expected life span of justice-involved people in the U.S., largely due to the risks associated with community reentry following incarceration. Justice-involved individuals are more likely to die of an opioid overdose compared to the general population. Drug overdose is among the leading causes of death for individuals re-entering the community, with a majority of these overdoses involving opioids. Studies show that medication for opioid use disorder (MOUD) reduces drug use, disease rates and overdose events, in addition to promoting recovery among individuals with opioid use disorders. Across the criminal justice system, MOUD has been found to reduce criminal activity, arrests, as well as probation revocations and re-incarcerations. MOUD in correctional settings should involve multi-disciplinary teams of health, behavioral health and security professionals. By incorporating multidisciplinary teams into MOUD programs for justice-involved individuals, collaborative and informed decisions about the person’s treatment can be made. THE IMPORTANCE OF A MULTIDISCIPLINARY APPROACH TO TREATING OPIOID USE DISORDER Achieving Collaborative Success and Improving Outcomes Across Correctional Disciplines

Sunday, Jan. 12th • 8:30–10 a.m. • Room W230A

Participants will be able to ... • Describe the benefits of a multidisciplinary approach to MOUD/OUD healthcare management from a medi cal, nursing, dental, behavioral health, administration and security perspective. • Understand the unique challenges and best practic es related to implementing and operating a MOUD

program in a correctional setting from a medical, nursing, dental, behavioral health, administration, and security perspective. • Articulate bio-ethical, social, clinical and public health complexities with opioid use disorder and the use of the medications for opioid use disorder with a correctional population.

SPEAKERS

Jerome Greenfield, M.D., DLFAPA Deputy Chief Officer–Psychiatry VitalCore Health Strategies, Topeka, Kansas

Laura E. Bedard, Ph.D. Chief of Corrections Seminole County Sheriff’s Office, Sanford, Florida Rebecca Neveau, RN CNA-Centurion Health Marion Correctional Institution, Marion, Florida

James Clare, DDS, MPH Dental Director

North Carolina Department of Adult Correction, Raleigh, North Carolina

Jennifer A. Urra, MPH, RN, CCHP Deputy Director of Holistic Services Ohio Department of Rehabilitation and Correction, Columbus, Ohio

107